Gene Information
Gene Name
|
MMP2 |
Gene ID
|
4313
|
Gene Full Name
|
matrix metallopeptidase 2 |
Gene Alias
|
CLG4; MONA; CLG4A; MMP-2; TBE-1; MMP-II |
Transcripts
|
ENSG00000087245
|
Virus
|
HBV |
Gene Type
|
protein coding |
HPA Location Info
|
Vesicles;Predicted to be secreted;
|
HPA Protein Class Info
|
Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins |
Uniport_ID
|
P08253
|
HGNC ID
|
HGNC:7166
|
VEGA ID
|
OTTHUMG00000133202
|
OMIM ID
|
120360 |
String ID
|
9606.ENSP00000219070
|
Drugbank ID
|
BE0000642
|
PharmGKB ID
|
PA30877
|
Target gene [MMP2] related to VISs
DVID |
Chromosome |
HM |
TFBS |
CA |
Sum of Overlapped Records |
Detail |
1005448 |
chr16 |
54 |
|
|
54 |
View |
Relationship between gene expression and immune infiltrating cell level
Data ID |
Disease |
Sample number |
Sample type |
LIHC (TCGA) |
Liver hepatocellular carcinoma |
424 |
Liver hepatocellular carcinoma HCV (HBV+)(86), Liver hepatocellular carcinoma HCV (HBV-)(19), Liver hepatocellular carcinoma (HBV+)(209), Liver hepatocellular carcinoma (HBV+)(60), Paracancerous HCV (HBV+)(4), Paracancerous (HBV-)(28), Paracancerous (HBV+)(18) |
> Dataset: LIHC
|
HeatMap of cell type fractions in all samples
|
Lollipop of MMP2 expression and immune infiltrating cell level correlation result in HBV+ samples
|
MMP2 expression: Low -> High
|
|
|
|
|